Last 82,200 KRW
Change Today +800.00 / 0.98%
Volume 349.2K
078160 On Other Exchanges
Symbol
Exchange
KOSDAQ
OTC US
As of 1:29 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

medipost co ltd (078160) Snapshot

Open
80,800
Previous Close
81,400
Day High
84,500
Day Low
79,700
52 Week High
03/3/15 - 84,500
52 Week Low
12/30/14 - 41,650
Market Cap
592.3B
Average Volume 10 Days
527.0K
EPS TTM
141.00
Shares Outstanding
7.2M
EX-Date
--
P/E TM
583.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIPOST CO LTD (078160)

Related News

No related news articles were found.

medipost co ltd (078160) Related Businessweek News

No Related Businessweek News Found

medipost co ltd (078160) Details

Medipost Co Ltd, a stem cell biotechnology company, provides services and develops products related to human umbilical cord blood and human umbilical cord blood derived mesenchymal stem cells. It offers cord blood banking services for hematopoietic stem cell transplantation (HSCT) cases. The company also offers adult stem cell drugs, including CARTISTEM used for the treatment of knee cartilage defects; and NEUROSTEM, which is used in the treatment of patients suffering from neuro-degenerative disorders, such as Alzheimer’s disease, amyotrophic lateral sclerosis, and stroke via recovery of functionality and tissues of the central nervous system. Its adult stem cell drugs also comprise PNEUMOSTEM used for the treatment of pulmonary disorders comprising bronchopulmonary dysplasia; and PROMOSTEM that promotes early engraftment of donor hematopoietic stem cells following transplantation and improves the success rate of HSCT while minimizing the adverse immune reactions from the HSCT recipients. In addition, Medipost Co Ltd provides vitamins and nutritional supplements for the benefits of the pregnant, kids, and the elderly. The company has a strategic partnership with Dong-A Pharmaceutical Co., Ltd. for post-marketing and long-term follow up study of CARTISTEM clinical trial phases. Medipost Co Ltd was founded in 2000 and is based in Seoul, South Korea.

Founded in 2000

medipost co ltd (078160) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medipost co ltd (078160) Key Developments

Medipost to Form Joint Venture with Jingyuan Bio-Tech, Ltd

Medipost has agreed to form a 50:50 joint venture (JV) with Jingyuan Bio-Tech, Ltd, to carry out clinical tests of Cartistem in China. Under the terms of the JV, both the partners will jointly invest USD 7 million each. Deal Value is USD 14 million. The JV, OrLife Bio, will have an exclusive license for the development and sales of Cartistem in China and be responsible for the manufacturing and registration of the product. The JV will be located in Taian, China and plans to initiate clinical trial of CARTISTEM in China in 2016 following about one year preparation period. MEDIPOST will be entitled for 50% of the JV's profit based on its equity holdings and in addition will receive license fee and royalty from the JV.

Medipost Co Ltd Presents at HSBC Asia Corporate Day 2014, Nov-17-2014

Medipost Co Ltd Presents at HSBC Asia Corporate Day 2014, Nov-17-2014 . Venue: The Mayfair Hotel, Stratton Street, London W1J 8LT, United Kingdom.

Medipost Co Ltd, Special/Extraordinary Shareholders Meeting, Dec 18, 2014

Medipost Co Ltd, Special/Extraordinary Shareholders Meeting, Dec 18, 2014., at 09:00 Korea Standard Time. Location: Bundang-gu, Seongnam, Gyeonggi-do, Korea Bio Park.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
078160:KS 82,200.00 KRW +800.00

078160 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 078160.
View Industry Companies
 

Industry Analysis

078160

Industry Average

Valuation 078160 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.2x
Price/Book 4.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIPOST CO LTD, please visit www.medi-post.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.